← Leaderboards
Michael A Taffe
Scripps Research Institute
$23,512,031
Attributed
$24,584,895
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,584,895 · 14
By mechanism
R01$22,077,741 · 10
T32$1,132,688 · 1
P20$850,694 · 1
R21$523,772 · 1
P30$0 · 1
Top collaborators
- Tobin J Dickerson3 shared
- Loren H Parsons2 shared
Most similar at Scripps Research Institute
Same institution · by research overlap
- Tobin J Dickerson$8,883,441
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteBehavioralPharmaceutical PreparationsMacaca MulattaBrainSelf AdministrationRattusNeuropsychological TestsLaboratoriesPerformanceDependenceReportingMethamphetamineAddictionDesignIntravenousChronicNonhuman PrimateMemoryMonkeysCognitiveRodentResponseAnimals
Grant awards (68)
Dissecting the Abuse Liability of Cathinone and Amphetamine Stimulants$395,000
R01 · FY2025 · DA · contact PI
Explicating Vulnerability and Resilience in Opioid Self-Administration in Middle Aged Rats$357,750
R01 · FY2025 · DA · contact PI
Dissecting the Abuse Liability of Cathinone and Amphetamine Stimulants$395,000
R01 · FY2024 · DA · contact PI
Explicating Vulnerability and Resilience in Opioid Self-Administration in Middle Aged Rats$357,750
R01 · FY2024 · DA · contact PI
Dissecting the Abuse Liability of Cathinone and Amphetamine Stimulants$395,000
R01 · FY2023 · DA · contact PI
Dissecting the Abuse Liability of Synthetic Cathinone Stimulants$354,375
R01 · FY2020 · DA · contact PI
Dissecting the Abuse Liability of Synthetic Cathinone Stimulants$354,375
R01 · FY2019 · DA · contact PI
Prescription Opioid Addiction: Neurobiological Mechanisms$433,125
R01 · FY2018 · DA · contact PI
Dissecting the Abuse Liability of Synthetic Cathinone Stimulants$433,125
R01 · FY2018 · DA · contact PI
Immunopharmacotherapy for Methamphetamine Addiction$286,785
R01 · FY2018 · DA · contact PI
Immunopharmacotherapy for Methamphetamine Addiction$158,286
R01 · FY2018 · DA · contact PI
Neuropsychopharmacology: Multidisciplinary Training$562,020
T32 · FY2017 · AA · contact PI
Cannabinoid regulation of cognition$551,934
R01 · FY2017 · DA · contact PI
Immunopharmacotherapy for Methamphetamine Addiction$481,250
R01 · FY2017 · DA · contact PI
Dissecting the Abuse Liability of Synthetic Cathinone Stimulants$433,125
R01 · FY2017 · DA · contact PI
Prescription Opioid Addiction: Neurobiological Mechanisms$433,125
R01 · FY2017 · DA · contact PI
Neuropsychopharmacology - Multidisciplinary Training$23,581
T32 · FY2017 · AA · contact PI
Neuropsychopharmacology - Multidisciplinary Training$547,087
T32 · FY2016 · AA · contact PI
Cannabinoid regulation of cognition$530,020
R01 · FY2016 · DA · contact PI
Immunopharmacotherapy for Methamphetamine Addiction$476,438
R01 · FY2016 · DA · contact PI
Dissecting the Abuse Liability of Synthetic Cathinone Stimulants$433,125
R01 · FY2016 · DA · contact PI
Prescription Opioid Addiction: Neurobiological Mechanisms$422,111
R01 · FY2016 · DA · contact PI
Cannabinoid regulation of cognition$706,390
R01 · FY2015 · DA · contact PI
Immunopharmacotherapy for Methamphetamine Addiction$466,643
R01 · FY2015 · DA · contact PI
Prescription Opioid Addiction: Neurobiological Mechanisms$419,979
R01 · FY2015 · DA · contact PI
Determinants of transition states in MDMA self-administration$374,103
R01 · FY2015 · DA · contact PI
Cannabinoid regulation of cognition$604,467
R01 · FY2014 · DA · contact PI
Immunopharmacotherapy for Methamphetamine Addiction$473,750
R01 · FY2014 · DA · contact PI
Prescription Opioid Addiction: Neurobiological Mechanisms$426,375
R01 · FY2014 · DA · contact PI
Determinants of transition states in MDMA self-administration$379,800
R01 · FY2014 · DA · contact PI
Cannabinoid regulation of cognition$157,918
R01 · FY2014 · DA · contact PI
Cannabinoid regulation of cognition$504,839
R01 · FY2013 · DA · contact PI
Determinants of transition states in MDMA self-administration$376,842
R01 · FY2013 · DA · contact PI
Immunopharmacotherapy for Methamphetamine Addiction$409,449
R01 · FY2012 · DA · contact PI
Behavioral Toxicity of Chronic Alcohol Drinking in Peri-Adolescent Monkeys$405,733
R01 · FY2012 · AA · contact PI
Determinants of transition states in MDMA self-administration$379,800
R01 · FY2012 · DA · contact PI
Determinants of transition states in MDMA self-administration$12,744
R01 · FY2012 · DA · contact PI
Immunopharmacotherapy for Methamphetamine Addiction$409,449
R01 · FY2011 · DA · contact PI
Behavioral Toxicity of Chronic Alcohol Drinking in Peri-Adolescent Monkeys$405,733
R01 · FY2011 · AA · contact PI
Determinants of transition states in MDMA self-administration$330,426
R01 · FY2011 · DA · contact PI
Behavioral Toxicity of Chronic Alcohol Drinking in Peri-Adolescent Monkeys$422,111
R01 · FY2010 · AA · contact PI
Immunopharmacotherapy for Methamphetamine Addiction$422,111
R01 · FY2010 · DA · contact PI
CONSEQUENCES OF CHRONIC EXPOSURE TO DELTA9-THC IN MONKEYS$223,550
P20 · FY2010 · DA · contact PI
Immunopharmacotherapy for Methamphetamine Addiction$426,375
R01 · FY2009 · DA · contact PI
Behavioral Toxicity of Chronic Alcohol Drinking in Peri-Adolescent Monkeys$426,375
R01 · FY2009 · AA · contact PI
BEHAVIORAL TOXICITY OF MDMA IN RHESUS MONKEYS$397,032
R01 · FY2009 · DA · contact PI
CONSEQUENCES OF CHRONIC EXPOSURE TO DELTA9-THC IN MONKEYS$215,595
P20 · FY2009 · DA · contact PI
Immunopharmacotherapy for Methamphetamine Addiction$426,375
R01 · FY2008 · DA · contact PI
Behavioral Toxicity of Chronic Alcohol Drinking in Peri-Adolescent Monkeys$426,375
R01 · FY2008 · AA · contact PI
BEHAVIORAL TOXICITY OF MDMA IN RHESUS MONKEYS$388,669
R01 · FY2008 · DA · contact PI
CONSEQUENCES OF CHRONIC EXPOSURE TO DELTA9-THC IN MONKEYS$220,351
P20 · FY2008 · DA · contact PI
BEHAVIORAL TOXICITY OF MDMA IN RHESUS MONKEYS$396,601
R01 · FY2007 · DA · contact PI
CONSEQUENCES OF CHRONIC EXPOSURE TO DELTA9-TETRAHYDROCANNABINOL IN MONKEYS$191,198
P20 · FY2007 · DA · contact PI
BEHAVIORAL TOXICITY OF MDMA IN RHESUS MONKEYS$408,446
R01 · FY2006 · DA · contact PI
COGNITIVE EFFECTS OF ALCOHOL IN PERI-ADOLESCENT MONKEYS$171,834
R21 · FY2006 · AA · contact PI
BEHAVIORAL TOXICITY OF MDMA IN RHESUS MONKEYS$418,275
R01 · FY2005 · DA
COGNITIVE EFFECTS OF ALCOHOL IN PERI-ADOLESCENT MONKEYS$175,969
R21 · FY2005 · AA
SIV Behavioral Pathology: Manipulation of Viral Load$416,700
R01 · FY2004 · MH
COGNITIVE EFFECTS OF ALCOHOL IN PERI-ADOLESCENT MONKEYS$175,969
R21 · FY2004 · AA
SIV Behavioral Pathology: Manipulation of Viral Load$416,700
R01 · FY2003 · MH
SIV Behavioral Pathology: Manipulation of Viral Load$416,700
R01 · FY2002 · MH
NEUROPHARMACOLOGY OF PRIMATE COGNITION$324,100
R01 · FY2002 · DA
CORE--BEHAVIORAL ASSESSMENT$0
P30 · FY2002 · MH
SIV Behavioral Pathology: Manipulation of Viral Load$398,925
R01 · FY2001 · MH
NEUROPHARMACOLOGY OF PRIMATE COGNITION$318,411
R01 · FY2001 · DA
CORE--BEHAVIORAL ASSESSMENT$0
P30 · FY2001 · MH
NEUROPHARMACOLOGY OF PRIMATE COGNITION$301,321
R01 · FY2000 · DA
CORE--BEHAVIORAL ASSESSMENT$0
P30 · FY2000 · MH